These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35665371)

  • 41. A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity.
    Walters JN; Ferraro B; Duperret EK; Kraynyak KA; Chu J; Saint-Fleur A; Yan J; Levitsky H; Khan AS; Sardesai NY; Weiner DB
    Mol Ther; 2017 Apr; 25(4):976-988. PubMed ID: 28237837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of Wilms' Tumor 1 (WT1) peptide vaccine with GM-CSF or CpG in patients with solid malignancy.
    Ohno S; Okuyama R; Aruga A; Sugiyama H; Yamamoto M
    Anticancer Res; 2012 Jun; 32(6):2263-9. PubMed ID: 22641661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas.
    Nakahara Y; Okamoto H; Mineta T; Tabuchi K
    Brain Tumor Pathol; 2004; 21(3):113-6. PubMed ID: 15696971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.
    Tsuboi A; Hashimoto N; Fujiki F; Morimoto S; Kagawa N; Nakajima H; Hosen N; Nishida S; Nakata J; Morita S; Sakamoto J; Oji Y; Oka Y; Sugiyama H
    Cancer Immunol Immunother; 2019 Feb; 68(2):331-340. PubMed ID: 30430205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.
    Koido S; Okamoto M; Kobayashi M; Shimodaira S; Sugiyama H
    Discov Med; 2017 Aug; 24(130):41-49. PubMed ID: 28950074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
    Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
    Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.
    Oka Y; Elisseeva OA; Tsuboi A; Ogawa H; Tamaki H; Li H; Oji Y; Kim EH; Soma T; Asada M; Ueda K; Maruya E; Saji H; Kishimoto T; Udaka K; Sugiyama H
    Immunogenetics; 2000 Feb; 51(2):99-107. PubMed ID: 10663572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.
    Lehe C; Ghebeh H; Al-Sulaiman A; Al Qudaihi G; Al-Hussein K; Almohareb F; Chaudhri N; Alsharif F; Al-Zahrani H; Tbakhi A; Aljurf M; Dermime S
    Cancer Res; 2008 Aug; 68(15):6350-9. PubMed ID: 18676860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.
    Rong Y; Cheng L; Ning H; Zou J; Zhang Y; Xu F; Liu L; Chang Z; Fu XY
    Cancer Res; 2006 Aug; 66(16):8049-57. PubMed ID: 16912181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [WT1 peptide cancer vaccine].
    Sugiyama H
    Nihon Rinsho; 2017 Feb; 75(2):263-269. PubMed ID: 30562862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
    Wagner KJ; Roberts SG
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cancer antigen WT1-targeting treatment for the malignancies].
    Oka Y; Kawase I
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):375-82. PubMed ID: 18974621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wilms' tumour gene 1 (WT1) in human neoplasia.
    Keilholz U; Menssen HD; Gaiger A; Menke A; Oji Y; Oka Y; Scheibenbogen C; Stauss H; Thiel E; Sugiyama H
    Leukemia; 2005 Aug; 19(8):1318-23. PubMed ID: 15920488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides.
    Nakata J; Nakajima H; Hayashibara H; Imafuku K; Morimoto S; Fujiki F; Motooka D; Okuzaki D; Hasegawa K; Hosen N; Tsuboi A; Oka Y; Kumanogoh A; Oji Y; Sugiyama H
    Oncotarget; 2018 Nov; 9(89):36029-36038. PubMed ID: 30542516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The WT1 gene--its role in tumourigenesis and prospects for immunotherapeutic advances.
    Lindstedt I; Lindgren MA; Andersson E; Engström W
    In Vivo; 2014; 28(5):675-81. PubMed ID: 25189877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical Development of a WT1 Oral Cancer Vaccine Using a Bacterial Vector to Treat Castration-Resistant Prostate Cancer.
    Kitagawa K; Gonoi R; Tatsumi M; Kadowaki M; Katayama T; Hashii Y; Fujisawa M; Shirakawa T
    Mol Cancer Ther; 2019 May; 18(5):980-990. PubMed ID: 30824610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.
    Hirabayashi K; Yanagisawa R; Saito S; Higuchi Y; Koya T; Sano K; Koido S; Okamoto M; Sugiyama H; Nakazawa Y; Shimodaira S
    Anticancer Res; 2018 Apr; 38(4):2227-2234. PubMed ID: 29599343
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.